Main article

The Food and Drug Administration (FDA) has sent notices of violation to GE Healthcare and Bracco Diagnostics for marketing claims related to their Visipaque and Isovue X-ray contrast agents.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

March 2010 - Table of Contents

DIIR March 2010 (Full PDF Issue)

RadNet, Alliance Eye More Acquisitions

MedPAC Considers Options for Slowing In-Office Ancillary Services

MedPAC Recommends 1 Percent Increase for Doctors in 2011

Eye on Imaging: Largest Imaging Providers Aim to Capitalize on Consolidation

CMS Chooses Three Groups to Accredit Imaging Suppliers

FDA Clears Fuji Digital Radiography System

GE Working to Expand Access of MRI Systems to Underdeveloped Regions

European PACS Market to Reach $848M by 2015

FDA Warns GE, Bracco Over Contrast Agent Claims

Bayer Settles NSF Case in California

Diagnostic Imaging Stocks Rise 2 Percent in Last Four Weeks

Market Scanner (March 2010)